AB-001
- Generic Name
- AB-001
- Drug Type
- Small Molecule
- Chemical Formula
- C23H24O6
- CAS Number
- 2663700-89-6
- Unique Ingredient Identifier
- TNM7KA4LB3
Phase 0/1 Study of 212Pb-NG001 in mCRPC
Early Phase 1
Completed
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- ARTBIO Inc.
- Target Recruit Count
- 3
- Registration Number
- NCT05725070
- Locations
- 🇳🇴
Oslo University Hospital, Oslo, Norway
Tolerability, Safety and Pharmacokinetics of a Topical AB001 Patch in Healthy Subjects
Phase 1
Completed
- Conditions
- Chronic Low Back Pain
- Interventions
- First Posted Date
- 2019-06-25
- Last Posted Date
- 2020-03-30
- Lead Sponsor
- Frontier Biotechnologies Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT03997734
- Locations
- 🇨🇳
The Third People's Hospital of Wuxi, Wuxi, Jiangsu, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath